Enhanced topical delivery of small hydrophilic or lipophilic active agents and epidermal growth factor by fractional radiofrequency microporation

Pharmaceutical Research

Volumn 29, Issue 7, 2012, Pages 2017-2029

  Kim, Jaekwan ^a   Jang, Ji Hye ^a   Lee, Ji Hae ^a   Choi, Jin Kyu ^a   Park, Woo Ram ^a   Bae, Il Hong ^a   Bae, Joonho ^a   Park, Jin Woo ^a  

^a AmorePacific Corporation   (South Korea)

Author keywords

ablation; epidermal growth factor; microporation; radiofrequency; topical delivery

Indexed keywords

BISABOLOL; EPIDERMAL GROWTH FACTOR; MELANIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEPIGMENTATION; DRUG DELIVERY SYSTEM; DRUG POTENTIATION; FEMALE; HYDROPHILICITY; HYPERPIGMENTATION; IN VITRO STUDY; LIPOPHILICITY; MEMBRANE TRANSPORT; MOLECULAR SIZE; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RADIOFREQUENCY MICROPORATION; REJUVENATION; SKIN DEFECT; SKIN INJURY; SKIN PERMEABILITY; TREATMENT RESPONSE; ULTRAVIOLET B RADIATION; WRINKLE;

ADMINISTRATION, CUTANEOUS; ANIMALS; DRUG DELIVERY SYSTEMS; EPIDERMAL GROWTH FACTOR; MICE; MICE, HAIRLESS; RADIO WAVES; SESQUITERPENES; SKIN; SKIN ABSORPTION; SKIN AGING; SKIN PIGMENTATION;

EID: 84862783742     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-012-0729-1     Document Type: Article

References (38)

1. Naik A, Kali YN, Guy RH. Transdermal drug delivery: Overcoming the skin's barrier function. Pharm Sci Technol Today. 2000;3(9):318-26.
2. Elias PM, Choi EH. Interactions among stratum corneum defensive functions. Exp Dermatol. 2005;14(10):719-26.
3. Prausnitz MR, Mitragotri S, Langer R. Current status and future potential of transdermal drug delivery. Nat Rev Drug Discov. 2004;3:115-24.
4. Singh TR, Garland MJ, Cassidy CM, Mijalska K, Demir YK, Abdelghany S, et al. Microporation techniques for enhanced delivery of therapeutic agents. Recent Pat Drug Deliv Formul. 2010;4(1):1-17.
5. Donnelly RF, Morrow DIJ, McCarron PA, Woolfson AD, Morrissey A, Juzenas P, et al. Microneedle-mediated intradermal delivery of 5-aminolevulinic acid: potential for enhanced topical photodynamic therapy. J Control Release. 2008;129(3):154-62.
6. Wu XM, Todo H, Sugibayashi K. Enhancement of skin permeation of high molecular compounds by a combination of microneedle pretreatment and iontophoresis. J Control Release. 2007;118(2):189-95.
7. Dubey S, Kalia YN. Non-invasive iontophoretic delivery of enzymatically active ribonuclease A (13.6 kDa) across intact porcine and human skins. J Control Release. 2010;145(3):203-9.
8. Polat BE, Hart D, Langer R, Blankschtein D. Ultrasound-mediated transdermal drug delivery: mechanisms, scope, and emerging trends. J Control Release. 2011;152(3):330-48.
9. Machet L, Boucaud A. Phonophoresis: efficiency, mechanisms and skin tolerance. Int J Pharm. 2002;243(1-2):1-15.
10. Baxter J, Mitragotri S. Jet-induced skin puncture and its impact on needle-free jet injections: experimental studies and a predictive model. J Control Release. 2005;106(3):361-73.
11. Stachowiak JC, Li TH, Arora A, Mitragotri S, Fletcher DA. Dynamic control of needle-free jet injection. J Control Release. 2009;135(2):104-12.
12. Han TH, Hah JM, Yoh JJ. Drug injection into fat tissue with a laser based microjet injector. J Appl Phys. 2011;109(9):093105.
13. Bachhav YG, Summer S, Heinrich A, Bragagna T, Böhler C, Kalia YN. Effect of controlled laser microporation on drug transport kinetics into and across the skin. J Control Release. 2010;146(1):31-6.
14. Lee WR, Shen SC, Pai MH, Yang HH, Yuan CY, Fang JY. Fractional laser as a tool to enhance the skin permeation of 5-aminolevulinic acid with minimal skin disruption: a comparision with conventional erbium:YAG laser. J Control Release. 2010;145(2):124-33.
15. Lee JW, Gadiraju P, Park JH, Allen MG, Prausnitz MR. Microsecond thermal ablation of skin for transdermal drug delivery. J Control Release. 2011;154(1):58-68.
16. Wong TW, Chen CH, Huang CC, Lin CD, Hui SW. Painless electroporation with a new needle-free microelectrode array to enhance transdermal drug delivery. J Control Release. 2006;110(3):557-65.
17. Sintov AC, Krymberk L, Daniel D, Hannan T, Sohn Z, Levin G. Radiofrequency-driven skin microchanneling as a new way for electrically assisted transdermal delivery of hydrophilic drugs. J Control Release. 2003;89(2):311-20.
18. Levin G, Gershonowitz A, Sacks H, Stern M, Sherman A, Rudaev S, et al. Transdermal delivery of human growth hormone through RF-microchnnels. Pharm Res. 2005;22(4):550-5.
19. Moetaz E, Tarek SE, Walid M, Osama M, Donna B, My GM, et al. Radiofrequency facial rejuvenation: Evidence-based effect. J Am Acad Dermatol. 2011;64(3):524-35.
20. Dierickx CC. Lasers, light and radiofrequency for treatment of acne. Med Laser Appl. 2004;19(4):196-204.
21. Mulholland RS, Paul MD, Chalfoun C. Noninvasive body contouring with radiofrequency, ultrasound, cryolipolysis, and low-level laser therapy. Clin Plast Surg. 2011;38(3):503-20.
22. Sadick N. Bipolar radiofrequency for facial rejuvenation. Facial Plast Surg Clin North Am. 2007;15(2):161-7.
23. El-Domyati M, El-Ammawi TS, Medhat W, Moawad O, Brennan D, Mahoney MG, et al. Radiofreqency facial rejuvenation: Evidence-based effect. J Am Acad Dermatol. 2011;64(3):524-35.
24. Berry MG, Davies D. Liposuction: A review of principles and techniques. J Plast Reconstr Aesthet Surg. 2011;64(8):985-92.
25. George H, Amy FT, Susannah LC, Stephen RM. Skin rejuvenation and wrinkle reduction using a fractional radiofrequency system. J Drugs Dermatol. 2009;8(3):259-65.
26. Rabe JH, Mamelak AJ, McElgunn PJS, Morison WL, Sauder DN. Photoaging: Mechanisms and repair. J Am Acad Dermatol. 2006;55(1):1-19.
27. Talwar HS, Griffiths CE, Fisher GJ, Hamilton TA, Voorhees JJ. Reduced type I and type III procollagens in photodamaged adult human skin. J Invest Dermatol. 1995;105:285-90.
28. Bernstein EF, Chen YQ, Kopp JB, Fisher L, Brown DB, Hahn PJ, et al. Long-term sun exposure alters the collagen of the papillary dermis. Comparison of sun-protected and photoaged skin by northern analysis, immunohistochemical staining, and confocal laser scanning microscopy. J Am Acad Dermatol. 1996;34(2):209-18.
29. Fitzpatrick RE, Rostan EF. Reversal of photodamage with topical growth factors: a pilot study. J Cosmet Laser Ther. 2003;5(1):25-34.
30. Vavbever R, Pliquett UF, Preat V, Weaver JC. Comparison of the effects of short, high-voltage and long medium voltage pulses on skin electrical and transport properties. J Control Release. 1999;60(1):35-47.
31. Lombry C, Dujardin N, Preat V. Transdermal delivery of macromolecules using skin electroporation. Pharm Res. 2000;17(1):32-7.
32. Sung KC, Fang JY, Wang JJ, Hu OY. Transdermal delivery of nalbuphine and its prodrugs by electroporation. Eur J Pharm Sci. 2003;18(1):63-70.
33. Vanbever R, Preat V. Factors affecting transdermal delivery of metoprolol by electroporation. Bioelectrochem Bioenerg. 1995;38(1):223-8.
34. Kim S, Lee J, Jung E, Huh S, Park JO, Lee JW, et al. Mechanisms of depigmentation by [alpha]-bisabolol. J Dermatol Sci. 2008;52(3):219-22.
35. Nishioka E, Funasaka Y, Kondoh H, Chakraborty AK, Mishima Y, Ichihashi M. Expression of tyrosinase, TRP-1 and TRP-2 in ultraviolet-irradiated human melanomas and melanocytes: TRP-2 protects melanoma cells from ultraviolet B induced apoptosis. Melanoma Res. 1999;9(5):433-43.
36. Watson RE, Griffiths CE. Photogenic aspects of cutaneous photoaging. J Cosmet Dermatol. 2005;4(4):230-6.
37. Le Pillouer-Prost A. Fibroblast: what's new in cellular biology? J Cosmet Laser Ther. 2003;5(3-4):232-8.
38. Kim WS, Park BS, Park SG, Kim HK, Sung JH. Antiwrinkle effect of adipose-derived stem cell: activation of dermal fibroblast by secretory factors. J Dermatol Sci. 2009;53(2):96-102.